US judge hears case challenging Myriad patents on BRCA cancer genes
This article was originally published in Scrip
Executive Summary
A US federal judge heard arguments on February 2nd in a lawsuit questioning the patentability of isolated human genes. However, it could be months before Judge Robert Sweet of the District Court for the Southern District of New York issues a ruling.